Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?

Chronic Hepatitis C Viral Infection Clinical Trial

Official title: Do Low HDL Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?

Status Completed

Clinical Trial Summary

The working hypothesis is that the low HDL serum level predict favorable response to anti viral treatment in chronic HCV (genotype 1) viral infection. This might be used to improve the rate of sustained virologic response.

Clinical Trial Description

Lipoproteins are closely connected to the process of hepatitis C virus (HCV) infection. Metabolic syndrome predicts negative treatment outcome in HCV infection.

Aim: to assess the association between lipids components of the metabolic syndrome and sustained viral response (SVR). ;

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Chronic Hepatitis C Viral Infection
• Hepatitis
• Hepatitis A
• Hepatitis C
• Hepatitis C, Chronic
• Hepatitis, Chronic
• Infection
• Virus Diseases

• NCT number: NCT01159613
• Study type: Observational
• Source: Ziv Hospital
• Status: Completed
• Phase: N/A
• Start date: April 2008
• Completion date: January 2009